Julie Yoo
Bio + Health

Julie Yoo


More About Julie

Julie Yoo is a General Partner on the Bio + Health team, where she leads investments in companies that are transforming how we access, pay for, and experience healthcare. Her portfolio includes AKASA, Ambience, Bayesian Health, Bold Health, Firefly Health, Marker Learning, Marley, Patina, Ribbon Health, Season Health, Sprinter Health, Thatch Health, Tomorrow Health, Topography, Turquoise Health and Zus Health. She is also a member of the Board of Directors at Bassett Healthcare Network.

Prior to joining Andreessen Horowitz, Julie was the cofounder and Chief Product Officer of Kyruus, a VC-backed healthtech company where she helped build and scale the business from 0 to 20M patients and over 225,000 healthcare providers across the US using their platform. Before that, Julie was VP of Product at Generation Health (acquired by CVS Health) and a Product Manager at Knome. Julie’s tech career began as an early member of the software engineering team at Endeca Technologies, which was acquired by Oracle.

Julie studied computer science and pre-medicine as an undergrad at MIT and obtained an MS in genomics from Harvard-MIT HST and an MBA from MIT Sloan. Julie is a Young Global Leader with the World Economic Forum and has been recognized through numerous awards and honors from Midas Brink List, Becker’s Hospital Review, Health Data Management, MedTech Boston, and Rock Health.

Featured Content

  • Commercializing AI in Healthcare: The Jobs to be Done
    Jay Rughani, Daisy Wolf, Vijay Pande, and Julie Yoo

    Building specialist AIs to perform healthcare tasks offers the most challenging technical problems in the field today, as well as the greatest opportunity for impact.

  • Investing in Hippocratic AI
    Julie Yoo and Justin Larkin

    The very nature of generative AI—conversational, scalable, accessible to non-technical users—has the potential to solve the shortcomings of previous generations of rules-based chatbots and other such products in making these concepts a reality.

  • Channel Partnerships in Healthcare
    Jay Rughani, Annie Collins, and Julie Yoo

    How can digital health founders successfully implement channel partnerships to accelerate the distribution of their products and services? When should they use them? How should they use them? We spoke with the founders of Omada, Ginger, and Cedar, each of which have successfully utilized channel partnerships, and surveyed 36 other digital health startups to analyze the state of channel partnerships in the market today.

  • Bio Eats World: Shaping Channel Partnerships with Sean Duffy
    Sean Duffy, Julie Yoo, Jay Rughani, and Olivia Webb

    Today’s episode is with Sean Duffy, cofounder and CEO of Omada Health. He is joined by a16z Bio + Health general partner Julie Yoo and investment partner Jay Rughani.

  • Today’s episode is with Florian Otto, cofounder and CEO of Cedar. He is joined by a16z Bio + Health general partner Julie Yoo.

Load More

Select Investments

Any investments or portfolio companies mentioned, referred to, or described on this page are not representative of all investments. A list of investments made by funds managed by a16z is available here:

go to top